日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

RHOV is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis

RHOV是一种对脱离有反应的Rho GTP酶,是卵巢癌腹膜转移所必需的。

Elhaw, Amal T; Tang, Priscilla W; Cheng, Ya-Yun; Kamlapurkar, Shriya; Javed, Zaineb; Al-Saad, Sarah; White, Sierra R; Abdelnaby, Ahmed Emam; Khan, Hannah; Choi, Alex Seok; Mattheyses, Alexa L; Cole, Aidan R; Kim, Yeon Soo; Atiya, Huda I; Trebak, Mohamed; Zervantonakis, Ioannis K; Buckanovich, Ronald J; Aird, Katherine M; Coffman, Lan G; Mythreye, Karthikeyan; Hempel, Nadine

Anoikis resistance and metastasis of ovarian cancer can be overcome by CDK8/19 mediator kinase inhibition

CDK8/19介导激酶抑制可以克服卵巢癌的抗凋亡和转移。

Monavarian, Mehri; Rajkarnikar, Resha; Page, Emily Faith; Kumari, Asha; Quintero Macias, Liz; Massicano, Felipe; Lee, Nam Y; Sahoo, Sarthak; Hempel, Nadine; Jolly, Mohit Kumar; Ianov, Lara; Worthey, Elizabeth; Singh, Abhyudai; Roninson, Igor B; Broude, Eugenia V; Chen, Mengqian; Mythreye, Karthikeyan

Targeting Mediator Kinase Cyclin-Dependent Kinases 8/19 Potentiates Chemotherapeutic Responses, Reverses Tumor Growth, and Prolongs Survival from Ovarian Clear Cell Carcinoma.

靶向介导激酶细胞周期蛋白依赖性激酶 8/19 可增强化疗反应,逆转肿瘤生长,延长卵巢透明细胞癌患者的生存期

Barton Wade C, Kumari Asha, Mack Zachary T, Schools Gary P, Quintero Liz Macias, Choi Alex Seok, Rangavajhula Karthik, Arend Rebecca C, Broude Eugenia V, Mythreye Karthikeyan

Loss of Predicted Cell Adhesion Molecule MPZL3 Promotes EMT in Ovarian Cancer.

预测细胞粘附分子 MPZL3 的缺失促进卵巢癌的 EMT

Cheng Ya-Yun, Worley Beth L, Javed Zaineb, Elhaw Amal T, Tang Priscilla W, Al-Saad Sarah, Kamlapurkar Shriya, White Sierra R, Uboveja Apoorva, Mythreye Karthikeyan, Aird Katherine M, Czyzyk Traci A, Hempel Nadine

RHOV is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis

RHOV是一种对脱离有反应的Rho GTP酶,是卵巢癌腹膜转移所必需的。

Elhaw, Amal T; Tang, Priscilla W; Cheng, Ya-Yun; Kamlapurkar, Shriya; Javed, Zaineb; Al-Saad, Sarah; White, Sierra R; Abdelnaby, Ahmed Emam; Khan, Hannah; Choi, Alex Seok; Cole, Aidan R; Kim, Yeon-Soo; Atiya, Huda I; Trebak, Mohamed; Zervantonakis, Ioannis; Buckanovich, Ronald J; Aird, Katherine M; Coffman, Lan G; Mythreye, Karthikeyan; Hempel, Nadine

GPX3 supports ovarian cancer tumor progression in vivo and promotes expression of GDF15.

GPX3 在体内支持卵巢癌肿瘤进展并促进 GDF15 的表达

Chang Caroline, Cheng Ya-Yun, Kamlapurkar Shriya, White Sierra, Tang Priscilla W, Elhaw Amal T, Javed Zaineb, Aird Katherine M, Mythreye Karthikeyan, Phaëton Rébécca, Hempel Nadine

Phosphoproteomic profiling identifies DNMT1 as a key substrate of beta IV spectrin-dependent ERK/MAPK signaling in suppressing angiogenesis

磷酸化蛋白质组学分析表明,DNMT1是βIV血影蛋白依赖性ERK/MAPK信号通路抑制血管生成的关键底物。

Flores, Paola Cruz; Ahmed, Tasmia; Podgorski, Julia; Ortiz, Hannah R; Langlais, Paul R; Mythreye, Karthikeyan; Lee, Nam Y

Targeted therapy in high grade serous ovarian Cancer: A literature review

高级别浆液性卵巢癌的靶向治疗:文献综述

Dinkins, Kaitlyn; Barton, Wade; Wheeler, Lauren; Smith, Haller J; Mythreye, Karthikeyan; Arend, Rebecca C

Loss of the predicted cell adhesion molecule MPZL3 promotes EMT and chemoresistance in ovarian cancer

预测的细胞黏附分子MPZL3的缺失会促进卵巢癌的EMT和化疗耐药性。

Cheng, Ya-Yun; Worley, Beth L; Javed, Zaineb; Elhaw, Amal T; Tang, Priscilla W; Al-Saad, Sarah; Kamlapurkar, Shriya; White, Sierra; Uboveja, Apoorva; Mythreye, Karthikeyan; Aird, Katherine M; Czyzyk, Traci A; Hempel, Nadine

Evolving roles of activins and inhibins in ovarian cancer pathophysiology

激活素和抑制素在卵巢癌病理生理学中的作用演变

Evans, Elizabeth T; Horst, Ben; Arend, Rebecca C; Mythreye, Karthikeyan